MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

HB0025

Search medical newsFind research, conditions and clinical updates
  • Home
  • HB0025
HB0025联合化疗治疗晚期非小细胞肺癌显示前景：来自Ⅱ期试验的研究解读
Posted inClinical Updates Oncology Respiratory

HB0025 Plus Chemotherapy Shows Promise in Treating Advanced Non-Small Cell Lung Cancer: Insights From a Phase 2 Trial

Posted by By MedXY 11/14/2026
HB0025, a bispecific antibody targeting PD-L1 and VEGF pathways, combined with chemotherapy, demonstrated encouraging efficacy and manageable safety in advanced non-small cell lung cancer patients, supporting further phase 3 evaluation.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Bioadhesive Polymer Toothpastes: Emerging Strategies Against Enamel Erosion and Abrasion
  • Cangrelor versus Crushed Ticagrelor in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the DAPT-SHOCK-AMI Randomised, Double-Blind Trial
  • Optimizing Management of Staphylococcus aureus Bloodstream Infections in Pediatric Oncology: The Crucial Role of Central Venous Catheter Removal
  • Improvement in Neuropsychological Function with Memantine Treatment Among Patients with Systemic Lupus Erythematosus: A Phase 2 Randomised Placebo-Controlled Clinical Trial
  • Oral Estrogen Therapy and Its Association with Porphyria Cutanea Tarda: Insights from a Danish Nationwide Study
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top